| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
radixin | 0.593 | 0.615 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 0.716 | 0.423 | 9.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
vertebrae development associated | 1.000 | 0.077 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
Ral GEF with PH domain and SH3 binding motif 2 | 0.805 | 0.154 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
BCAS3 microtubule associated cell migration factor | 0.716 | 0.538 | 1.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ATPase family AAA domain containing 2B | 0.760 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ganglioside induced differentiation associated protein 1 | 0.612 | 0.538 | 3.2E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
syntrophin gamma 2 | 0.890 | 0.077 | 1.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
RAB4B, member RAS oncogene family | 0.890 | 0.192 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
plectin | 0.523 | 0.808 | 8.3E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
cyclin dependent kinase 12 | 0.638 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
peptidyl arginine deiminase 3 | 0.780 | 0.192 | 2.4E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SLC2A4 regulator | 0.615 | 0.692 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
pregnancy specific beta-1-glycoprotein 11 | 1.000 | 0.038 | 4.8E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
proteasome 20S subunit alpha 4 | 0.716 | 0.385 | 0.60 |
|
phenotype | 0.100 | None | 1.000 | 1 | 11 | 2015 | 2015 | ||||||||
|
HAS2 antisense RNA 1 | 0.729 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
RNA binding motif single stranded interacting protein 1 | 0.861 | 0.231 | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
retinoic acid receptor beta | 0.478 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2019 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
RAB5B, member RAS oncogene family | 0.722 | 0.346 | 2.6E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
protein tyrosine phosphatase receptor type D | 0.584 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
protein phosphatase 4 regulatory subunit 4 | 1.000 | 0.038 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
leucine rich repeat containing 4C | 0.792 | 0.192 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
PR/SET domain 11 | 0.839 | 0.231 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |